title: American Chemical Society--227th Annual Meeting. New disclosures. 28 March - 1 April 2004, Anaheim, CA, USA.
authors.affiliation: Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. Redmond.Garvey@thomson.com
authors.forename: Redmond
authors.initials: R
authors.lastname: Garvey
authors.forename: Claire
authors.initials: C
authors.lastname: Veryard
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis / Q000494:pharmacology; D003546:Cysteine Endopeptidases / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000138:chemical synthesis / Q000494:pharmacology; D006801:Humans; D061965:Matrix Metalloproteinase Inhibitors; D009097:Multienzyme Complexes / Q000187:drug effects; D010600:Pharmacology / Q000639:trends*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D046988:Proteasome Endopeptidase Complex; D011506:Proteins / Q000037:antagonists & inhibitors; D011944:Receptors, Androgen / Q000187:drug effects
chemical_list: D000962:Antimalarials; D005343:Fibrinolytic Agents; D061965:Matrix Metalloproteinase Inhibitors; D009097:Multienzyme Complexes; D010726:Phosphodiesterase Inhibitors; D011506:Proteins; D011944:Receptors, Androgen; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex